Jushi Holdings, other pot stocks rise after Virginia legalization vote

Jushi Holdings, other pot stocks rise after Virginia legalization vote
herbalhemp / Pixabay

Lawmakers in Virginia have voted to legalize recreational cannabis, and Jushi Holdings and other weed stocks are rising as a result. Gov. Ralph Northam is expected to sign the bill into law. One analyst boosted his price target for Jushi Holdings following Virginia’s legalization of recreational marijuana.

Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

Q4 2020 hedge fund letters, conferences and more

Virginia votes to legalize recreational pot

Virginia's House of Representatives and Senate approved a bill that would legalize recreational marijuana over the weekend. Although recreational sales won't begin until 2024, another piece of legislation that allows flower sales for the state's medical program is also heading to the governor's desk. Northam is expected to sign that bill as well.

Hedge Fund Launches Jump Despite Equity Market Declines

Last year was a bumper year for hedge fund launches. According to a Hedge Fund Research report released towards the end of March, 614 new funds hit the market in 2021. That was the highest number of launches since 2017, when a record 735 new hedge funds were rolled out to investors. What’s interesting about Read More

Flower sales for the medical program are expected to start in the fall. Additionally, within the recreational cannabis program, vertical integration will be allowed for current medical operators. Canaccord Genuity analyst Bobby Burleson sees this as a positive for Jushi Holdings.

He noted that when flower was allowed for Florida's medical program, the company's sales spiked significantly. He expects a similar positive dynamic in Virginia.

Price target raised for Jushi Holdings

Thus, Burleson raised his price target for Jushi Holdings from $8 to $10 per share and maintained his Speculative Buy rating. He said the company is "in pole position occupying Health Service Area II" in northern Virginia adjacent to Washington, D.C. Thus, Burleson believes Jushi Holdings will benefit meaningfully, especially with cultivation expansion.

The company is already a permitted pharmaceutical processor in Virginia, with one store open and another two expected by late this year. Its designation as a Health Service Area II provider is positive because the region is geographically the smallest but also the most densely populated of the five HSAs. It captures almost 30% of Virginia's population and is home to two of the state's highest-income counties and half of Virginia's richest 10 neighborhoods.

He added that the company's 2021 numbers should see some positive impact, but most of the increase should start next year because flower sales won't begin until late this year. Burleson believes Jushi Holdings will command a premium multiple on his increased 2022 estimated EBITDA due to its leading position in the Virginia market.

He raised his revenue estimate for this year from $230 million to $233 million for next year from $350 million to $362 million. This year's EBITDA estimate rises from $46.1 million to $46.9 million, while next year's estimate increases from $104.6 million to $108 million.

Updated on

Michelle Jones is editor-in-chief for ValueWalk.com and has been with the site since 2012. Previously, she was a television news producer for eight years. She produced the morning news programs for the NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spent a short time at the CBS affiliate in Huntsville. She has experience as a writer and public relations expert for a wide variety of businesses. Email her at Mjones@wordpress-785388-2679526.cloudwaysapps.com.
Previous article These Are The Top Ten Technical Analysts Of 2020
Next article “Lethal Racist Loophole” May Soon Be Closed

No posts to display